FdaApplication
NDA 202611
Identifiers
- fda_app_no: NDA202611
Properties
| Property | Value |
|---|---|
| applicant_name | ASTELLAS PHARMA GLOBAL DEVELOPMENT INC |
| application_type | NDA |
| approval_date | 2012-06-28 |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| MYRBETRIQ | MIRABEGRON | 50MG | TABLET, EXTENDED RELEASE;ORAL |
| MYRBETRIQ | MIRABEGRON | 25MG | TABLET, EXTENDED RELEASE;ORAL |
2 products